Letter to the editorAlterations in l-arginine metabolism in first-episode schizophrenia patients: Further evidence for early metabolic dysregulation
Section snippets
Contributors
B.M. recruited and assessed study participants, performed statistical analysis and was involved in writing the manuscript. J.W. and M.G.F. performed biochemical measurements and were involved in writing the manuscript. D.F. consulted data analysis and was involved in writing the manuscript.
Conflict of interest
None to declare.
Acknowledgement
Authors are deeply grateful to all patients and healthy controls for participation in this study. Recruitment, clinical assessment and collection of biological material were supported by the research grant awarded by National Science Centre (grant number: DEC-2011/03/N/NZ5/00248). Assessment of biochemical parameters was supported by the research grant provided by Ministry of Science and Higher Education (grant number: N N402 467540). Błażej Misiak is supported by the START scholarship awarded
References (10)
- et al.
Plasma asymmetric dimethylarginine (ADMA) concentrations in patients with first and multiple episode schizophrenia
Psychiatry Res.
(2011) - et al.
Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production
Neurosci. Lett.
(1996) - et al.
Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism
Psychiatry Res.
(2016) - et al.
Plasma concentrations of three methylated arginines, endogenous nitric oxide synthase inhibitors, in schizophrenic patients undergoing antipsychotic drug treatment
Psychiatry Res.
(2016) - et al.
Asymmetric dimethylarginine (ADMA) and treatment response relationship in male patients with first-episode schizophrenia: a controlled study
Psychiatry Res.
(2014)
Cited by (4)
Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosis
2021, Biomarkers in NeuropsychiatryCitation Excerpt :Arginine metabolism is linked to that of proline and glutamate (both significantly up-regulated in FEP). Decreased arginine levels have been reported in prior studies of FEP and schizophrenia in serum (Misiak, Wisniewski, Fleszar, & Frydecka, 2016; Nedic Erjavec et al., 2018) and brain (P. Liu et al., 2016). Cao et al. (2018) reported significantly decreased serum arginine and threonine in schizophrenia, matching our findings.
Amino acids and acylcarnitines as potential metabolomic markers of schizophrenia: New approaches to diagnostics and therapy
2019, Bulletin of Siberian MedicineMonitoring and Treating Metabolic Abnormalities in Patients with Early Psychosis Initiated on Antipsychotic Medications
2018, Community Mental Health JournalL-arginine add-on treatment for schizophrenia: A randomized, double-blind, placebo-controlled, crossover study
2018, Turk Psikiyatri Dergisi
- 1
Authors with equal contribution